Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors. (Q52297317)
Jump to navigation
Jump to search
scientific article published on 22 September 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors. |
scientific article published on 22 September 2010 |
Statements
1 reference
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors. (English)
1 reference
Matthew D Galsky
1 reference
Daniel D Von Hoff
1 reference
Marcus Neubauer
1 reference
Thomas Anderson
1 reference
Mark Fleming
1 reference
Yasir Nagarwala
1 reference
Janine M Mahoney
1 reference
Dawn Midwinter
1 reference
Linda Vocila
1 reference
Tal Z Zaks
1 reference
22 September 2010
1 reference
30
1 reference
2
1 reference
695-701
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference